First Time Loading...

Perrigo Company PLC
NYSE:PRGO

Watchlist Manager
Perrigo Company PLC Logo
Perrigo Company PLC
NYSE:PRGO
Watchlist
Price: 33.15 USD 0.27%
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one PRGO stock under the Base Case scenario is 96.46 USD. Compared to the current market price of 33.15 USD, Perrigo Company PLC is Undervalued by 66%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PRGO Relative Value
Base Case
96.46 USD
Undervaluation 66%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
84
vs Industry
72
Median 3Y
1.1
Median 5Y
1.3
Industry
2.4
Forward
0.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-48
Median 5Y
-34.3
Industry
22.9
Forward
13.9
More Details
11.1
P/OCF
P/OCF
Price to OCF
11.1
vs History
69
vs Industry
34
Median 3Y
16.3
Median 5Y
13.9
Industry
17.1
More Details
35.4
P/FCFE
P/FCFE
Price to FCFE
35.4
vs History
12
vs Industry
16
Median 3Y
14.6
Median 5Y
14.6
Industry
23.2
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
73
vs Industry
64
Median 3Y
1
Median 5Y
1
Industry
2.1
More Details
1.6
EV/S
EV/S
Enterprise Value to Sales
1.6
vs History
77
vs Industry
61
Median 3Y
1.8
Median 5Y
1.9
Industry
2.6
Forward
1.6
More Details
4.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.4
vs History
79
vs Industry
46
Median 3Y
5.1
Median 5Y
5.5
Industry
5.1
More Details
11.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.5
vs History
63
vs Industry
31
Median 3Y
12.6
Median 5Y
12.8
Industry
13.6
Forward
10.1
More Details
26
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
26
vs History
58
vs Industry
18
Median 3Y
32.3
Median 5Y
32.3
Industry
17
Forward
14.3
More Details
18.2
EV/OCF
EV/OCF
Enterprise Value to OCF
18.2
vs History
60
vs Industry
25
Median 3Y
26.5
Median 5Y
20
Industry
15.8
More Details
24.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
24.3
vs History
55
vs Industry
18
Median 3Y
26.7
Median 5Y
26.3
Industry
17.6
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
76
vs Industry
67
Median 3Y
0.8
Median 5Y
0.8
Industry
1.9
More Details

Multiples Across Competitors

PRGO Competitors Multiples
Perrigo Company PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IE
Perrigo Company PLC
NYSE:PRGO
4.5B USD 1 -353.7 11.5 26
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
699.8B USD 21 136.9 61.8 71
DK
Novo Nordisk A/S
CSE:NOVO B
3.8T DKK 16 44.8 32.7 35.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
356.7B USD 4.4 8.9 11.9 15.7
US
Merck & Co Inc
NYSE:MRK
322.3B USD 5.3 140.8 33.5 53.1
UK
AstraZeneca PLC
LSE:AZN
186.4B GBP 5.1 39.5 140.7 225.8
CH
Novartis AG
SIX:NOVN
180.1B CHF 4.3 13.4 9.8 16.2
CH
Roche Holding AG
SIX:ROG
172.6B CHF 2.9 15 8.6 10.2
US
Pfizer Inc
NYSE:PFE
155.8B USD 2.7 73.8 11 16.3
P/E Multiple
Earnings Growth
IE
Perrigo Company PLC
NYSE:PRGO
Average P/E: 59.2
Negative Multiple: -353.7 		N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
136.9
346%
DK
Novo Nordisk A/S
CSE:NOVO B
44.8
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
8.9
-20%
US
Merck & Co Inc
NYSE:MRK
140.8
7 454%
UK
AstraZeneca PLC
LSE:AZN
39.5
168%
CH
Novartis AG
SIX:NOVN
13.4
15%
CH
Roche Holding AG
SIX:ROG
15
26%
US
Pfizer Inc
NYSE:PFE
73.8
680%

See Also

Summary
PRGO intrinsic value, competitors valuation, and company profile.
DCF Valuation
PRGO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PRGO stock valuation using valuation multiples.
Wall Street Estimates
PRGO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PRGO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.